Skip to Main Content

Author Details

Michael Rehli
University Hospital Regensburg
1995
122
50
PMIDPaper TitleJournal TitlePublished Year
36741028Glutamine synthetase expression rescues human dendritic cell survival in a glutamine-deprived environment.Front Oncol2023
37883975Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas.Cell Rep Med2023
37641864Changes in adenoviral chromatin organization precede early gene activation upon infection.EMBO J2023
37565910A multilocus genetic risk score for obesity: Association with BMI and metabolic alterations in a cohort with severe obesity.Medicine (Baltimore)2023
34591983Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.Int J Cancer2022
35606086Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation.J Immunother Cancer2022
36161919Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy.Proc Natl Acad Sci U S A2022
35879286Postmitotic differentiation of human monocytes requires cohesin-structured chromatin.Nat Commun2022
35073416Physiological levels of 25-hydroxyvitamin D<sub>3</sub> induce a suppressive CD4<sup>+</sup> T cell phenotype not reflected in the epigenetic landscape.Scand J Immunol2022
33081589Associations of site-specific CD4<sup><b>+</b></sup>-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus.Lupus2021
33789089Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.Immunity2021
33563611The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.Cancer Immunol Res2021
33692344The epigenetic pioneer EGR2 initiates DNA demethylation in differentiating monocytes at both stable and transient binding sites.Nat Commun2021
33831168Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML.Blood2021
34779418Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone.J Clin Invest2021
34284675Methyl donor micronutrients, CD40-ligand methylation and disease activity in systemic lupus erythematosus: A cross-sectional association study.Lupus2021
32098963Author Correction: Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.Nat Commun2020
31964861Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.Nat Commun2020
31924477Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF.Immunity2020
30962454Rbpj expression in regulatory T cells is critical for restraining T<sub>H</sub>2 responses.Nat Commun2019
29925905Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.Leukemia2019
31378787C-Jun drives melanoma progression in PTEN wild type melanoma cells.Cell Death Dis2019
29154771In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors.J Immunol Methods2018
30315124Temporal autoregulation during human PU.1 locus SubTAD formation.Blood2018
29494619Shared activity patterns arising at genetic susceptibility loci reveal underlying genomic and cellular architecture of human disease.PLoS Comput Biol2018
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
28263993Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease.PLoS Genet2017
28934472Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation.Nucleic Acids Res2017
28829439An integrated expression atlas of miRNAs and their promoters in human and mouse.Nat Biotechnol2017
26966090An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.Blood2016
27556305Molecular dissection of the valproic acid effects on glioma cells.Oncotarget2016
27337479Transcriptional Regulation and Macrophage Differentiation.Microbiol Spectr2016
25261094Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia.Haematologica2015
25949862Identification and characterization of the specific murine NK cell subset supporting graft-<i>versus</i>-leukemia- and reducing graft-<i>versus</i>-host-effects.Oncoimmunology2015
25717144Technical Advance: Transcription factor, promoter, and enhancer utilization in human myeloid cells.J Leukoc Biol2015
25723102Gateways to the FANTOM5 promoter level mammalian expression atlas.Genome Biol2015
25450522Genome-wide identification of hypoxia-inducible factor-1 and -2 binding sites in hypoxic human macrophages alternatively activated by IL-10.Biochim Biophys Acta2015
25582773Lactic acid delays the inflammatory response of human monocytes.Biochem Biophys Res Commun2015
23912455Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.Oncogene2014
24944583Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.Genome Med2014
24670763An atlas of active enhancers across human cell types and tissues.Nature2014
24670764A promoter-level mammalian expression atlas.Nature2014
24671955Transcription and enhancer profiling in human monocyte subsets.Blood2014
24671953The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations.Blood2014
23296965Enrichment of methylated DNA by methyl-CpG immunoprecipitation.Methods Mol Biol2013
24068958Chromatin-specific regulation of mammalian rDNA transcription by clustered TTF-I binding sites.PLoS Genet2013
23874405New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.PLoS One2013
23658224Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1.Nucleic Acids Res2013
237055935-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes.Genome Biol2013
23482607Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.J Clin Endocrinol Metab2013
  • 1 - 50 of 122

Recommended Authors

David Langlais
McGill University
Career Start Year 2008
Number of shared co-authors 2
Deborah R Winter
Northwestern University Feinberg School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Matthias Farlik
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2007
Number of shared co-authors 3
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
David L Corcoran
The University of North Carolina at Chapel Hill
Career Start Year 2005
Number of shared co-authors 3
Ido Amit
Weizmann Institute of Science
Career Start Year 2004
Number of shared co-authors 14
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Hans-J??rg Warnatz
Max Planck Institute for Molecular Genetics
Career Start Year 2002
Number of shared co-authors 5
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
David K Crossman
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Martin Hirst
University of British Columbia
Career Start Year 1998
Number of shared co-authors 8
Jonathan Schug
University of Pennsylvania Perelman School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 1
Jeffrey J Delrow
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 1992
Number of shared co-authors 0
Kevin G Becker
National Institute on Aging, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 5
Timothy R Hughes
University of Toronto
Career Start Year 1992
Number of shared co-authors 3
Laszlo Nagy
University of Debrecen
Career Start Year 1991
Number of shared co-authors 0
Claus Nerlov
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 1990
Number of shared co-authors 5
Luiz F L Reis
Universidade Federal de Santa Maria
Career Start Year 1988
Number of shared co-authors 0
Peter Ghazal
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 4
Marian J A Groot Koerkamp
Princess Maxima Center for Pediatric Oncology Research
Career Start Year 1983
Number of shared co-authors 1
Anjana Rao
La Jolla Institute for Immunology
Career Start Year 1983
Number of shared co-authors 4
Christopher K Glass
University of California San Diego
Career Start Year 1983
Number of shared co-authors 13
Stephan Beck
UCL Cancer Institute, University College London
Career Start Year 1983
Number of shared co-authors 10
Jeremy M Boss
Emory University School of Medicine
Career Start Year 1976
Number of shared co-authors 0
Bruce J Aronow
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 9
Louise C Showe
The Wistar Institute
Career Start Year 1975
Number of shared co-authors 2
Daniel G Tenen
Harvard Stem Cell Institute, Harvard Medical School
Career Start Year 1975
Number of shared co-authors 9
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 5

Collaborators

Claudia Gebhard
University Hospital Regensburg
Co-authored papers 25
Christian Schmidl
Leibniz Institute for Immunotherapy
Co-authored papers 18
David A Hume
Mater Research Institute-UQ, Translational Research Institute
Co-authored papers 15
Lucia Schwarzfischer
University Hospital Regensburg
Co-authored papers 15
Matthias Edinger
Regensburg University Hospital
Co-authored papers 14
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Co-authored papers 13
Yoshihide Hayashizaki
Center for Integrative Medical Sciences
Co-authored papers 13
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers 12
Piero Carninci
RIKEN Center for Integrative Medical Sciences
Co-authored papers 12
Timo Lassmann
Telethon Kids Institute, University of Western Australia
Co-authored papers 11
Carsten O Daub
International Institute of Molecular and Cell Biology in Warsaw
Co-authored papers 9
Masayoshi Itoh
RIKEN Center for Integrative Medical Sciences
Co-authored papers 9
Harukazu Suzuki
RIKEN Center for Integrative Medical Sciences
Co-authored papers 9
Johanna Raithel
Leibniz Institute for Immunotherapy, c/o University Hospital Regensburg
Co-authored papers 8
Erik Arner
RIKEN Center for Integrative Medical Sciences (IMS)
Co-authored papers 8
Marina Lizio
Cerevance Ltd
Co-authored papers 7
Jun Kawai
RIKEN Center for Integrative Medical Sciences
Co-authored papers 7
Jessica Severin
Center for Integrative Medical Sciences
Co-authored papers 7
Dieter Weichenhan
German Cancer Research Center (DKFZ)
Co-authored papers 7
Christine A Wells
The University of Melbourne
Co-authored papers 7
Albin Sandelin
University of Copenhagen
Co-authored papers 6
Christoph Plass
German Cancer Research Center
Co-authored papers 6
John Kenneth Baillie
Roslin Institute, University of Edinburgh
Co-authored papers 6
Dagmar Glatz
University Hospital Regensburg
Co-authored papers 6
Peter Heutink
German Center for Neurodegenerative Diseases (DZNE).
Co-authored papers 5
Nicolas Bertin
University Bordeaux, CNRS
Co-authored papers 5
Kim M Summers
Mater Research Institute-University of Queensland, Translational Research Institute
Co-authored papers 5
Geoffrey J Faulkner
Mater Research Institute - University of Queensland
Co-authored papers 5
Sven Heinz
U.C. San Diego School of Medicine
Co-authored papers 5
Andreas Lennartsson
Karolinska Institute
Co-authored papers 5
Release 1.2